Communiqués

15/11/24 Boston Scientific Closes Acquisition of Axonics, Inc. PR
07/11/24 Axonics : Reports Third Quarter 2024 Financial Results Form 8 K PU
07/11/24 Axonics: Q3 Earnings Snapshot AQ
07/11/24 Axonics Reports Third Quarter 2024 Financial Results BU
26/09/24 Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia BU
19/09/24 Axonics Prevails in Patent Infringement Lawsuit with Medtronic BU
01/08/24 Axonics: Q2 Earnings Snapshot AQ
01/08/24 Axonics Reports Second Quarter 2024 Financial Results BU
26/07/24 Kestra Medical Technologies Announces Appointment of Veteran Medical Device Executive, Raymond W. Cohen, to its Board of Directors AQ
16/05/24 Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia BU
30/04/24 Axonics: Q1 Earnings Snapshot AQ
30/04/24 Axonics Reports First Quarter 2024 Financial Results BU
24/04/24 Boston Scientific Announces Results for First Quarter 2024 PR
25/03/24 Axonics Stockholders Approve Merger Agreement with Boston Scientific AQ
22/03/24 Axonics Stockholders Approve Merger Agreement with Boston Scientific BU
28/02/24 Axonics: Q4 Earnings Snapshot AQ
27/02/24 AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX BU
31/01/24 Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 PR
10/01/24 AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX BU
08/01/24 AXNX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Axonics to Boston Scientific AQ
08/01/24 Boston Scientific Announces Agreement to Acquire Axonics, Inc. PR
28/12/23 BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors AQ
28/12/23 Axonics to Present at the 42nd Annual J.P. Morgan Healthcare Conference AQ
27/12/23 Axonics to Present at the J.P. Morgan Healthcare Conference BU
01/11/23 Axonics to Participate in November Investor Conferences BU
Aucun résultat pour cette recherche
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT